A61K 9/008
Comprising drug dissolved or suspended in liquid propellant for inhalation via a
Official title: {comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]}
A61K9/008 (Comprising drug dissolved or suspended in liquid propellant for inhalation via a) appears on 843 US grants and 1,365 published applications in this corpus.
Search patents in A61K- Granted patents
- 843
- Published applications
- 1,365
- Assignees
- 488
- Inventors
- 1,847
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 0 | 0 |
| 1992 | 7 | 0 |
| 1993 | 7 | 0 |
| 1994 | 8 | 0 |
| 1995 | 7 | 0 |
| 1996 | 9 | 0 |
| 1997 | 28 | 0 |
| 1998 | 21 | 0 |
| 1999 | 19 | 0 |
| 2000 | 27 | 0 |
| 2001 | 33 | 7 |
| 2002 | 37 | 60 |
| 2003 | 46 | 77 |
| 2004 | 25 | 73 |
| 2005 | 16 | 82 |
| 2006 | 14 | 54 |
| 2007 | 23 | 57 |
| 2008 | 19 | 39 |
| 2009 | 16 | 58 |
| 2010 | 17 | 34 |
| 2011 | 16 | 36 |
| 2012 | 25 | 42 |
| 2013 | 25 | 40 |
| 2014 | 31 | 59 |
| 2015 | 24 | 58 |
| 2016 | 32 | 55 |
| 2017 | 35 | 62 |
| 2018 | 26 | 33 |
| 2019 | 32 | 58 |
| 2020 | 31 | 58 |
| 2021 | 35 | 72 |
| 2022 | 23 | 68 |
| 2023 | 28 | 57 |
| 2024 | 20 | 47 |
| 2025 | 26 | 46 |
| 2026 | 23 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Methods of treating eosinophilic esophagitis and reducing candidiasis28 Jul 2026US 12,691,128 B2Ellodi Pharmaceuticals, L.P.
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Aerosolized formulations of HIV protease inhibitors for the treatment of airway reflux14 Jul 2026US 12,678,453 B2The Medical College of Wisconsin, Inc.
- Anticancer compounds selective for ER-positive cancers16 Jun 2026US 12,655,104 B2The Board of Trustees of the University of Illinois Urbana, Illinois
- Aerosolized formulations of hiv protease inhibitors for the treatment of airway reflux10 Sep 2026US 2026/0263489 A1The Medical College of Wisconsin, Inc.
- Antiarrhythmic formulation27 Aug 2026US 2026/0248776 A1InCarda Therapeutics, Inc.
- Aerosolized formulations of hiv protease inhibitors for the treatment of airway reflux27 Aug 2026US 2026/0248827 A1The Medical College of Wisconsin, Inc.
- Metered dose inhalers and high-dose suspensions27 Aug 2026US 2026/0249027 A1Kindeva Drug Delivery L. P.
- Metered dose inhalers and solutions including cannabinoids in hfa-152a20 Aug 2026US 2026/0241119 A1Kindeva Drug Delivery L. P.
Most cited
By later US patents
- Method and apparatus for administering dehydrated liposomes by inhalation353US 4,895,719 ALiposome Technology, Inc. · 1990
- Steroidal aerosol compositions and process for the preparation thereof325US 4,044,126 AAllen & Hanburys Limited · 1977
- Chemical compounds300US 4,364,923 AAllen & Hanburs Limited · 1982
- Micronized aerosol steroids296US 4,414,209 AAllen & Hanburys Limited · 1983
- Method of administration of insulin296US 5,364,838 AMiris Medical Corporation · 1994